APA (7th ed.) Citation

CI, C., JF, L., IC, C., CH, L., HH, C., MH, C., . . . YW, P. (2026). Association of sodium-glucose cotransporter 2 inhibitors with the risk of incident anxiety and insomnia: A retrospective cohort study using the TriNetX database. Diabetes & metabolic syndrome, 20(1), 103373. https://doi.org/10.1016/j.dsx.2025.103373

Chicago Style (17th ed.) Citation

CI, Chang, Lin JF, Chen IC, Lin CH, Chen HH, Chang MH, Tang CL, and Pai YW. "Association of Sodium-glucose Cotransporter 2 Inhibitors with the Risk of Incident Anxiety and Insomnia: A Retrospective Cohort Study Using the TriNetX Database." Diabetes & Metabolic Syndrome 20, no. 1 (2026): 103373. https://doi.org/10.1016/j.dsx.2025.103373.

MLA (9th ed.) Citation

CI, Chang, et al. "Association of Sodium-glucose Cotransporter 2 Inhibitors with the Risk of Incident Anxiety and Insomnia: A Retrospective Cohort Study Using the TriNetX Database." Diabetes & Metabolic Syndrome, vol. 20, no. 1, 2026, p. 103373, https://doi.org/10.1016/j.dsx.2025.103373.